Tech Company Financing Transactions

Vilya Funding Round

On 6/4/2024, Vilya announced $71 million in Series A financing from Arch Venture Partners, Altitude Life Science Ventures and LifeForce Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Seattle, WA Undisclosed
USA

Phone

Undisclosed

Website

www.vilyatx.com

Email Address

Not Recorded

Overview

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Co-Founder

Robert Nelsen

        

Browse more venture capital transactions:

Prev: 6/4/2024: SciTech Development venture capital transaction
Next: 6/4/2024: AirMDR venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary